Related Experiment Video
Updated: Jun 10, 2026
14:48
Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle
Wan-Seob Cho1, Rodger Duffin, Craig A Poland
1ELEGI (The Edinburgh Lung and the Environment Group Initiative), Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom.
Environmental Health Perspectives
|August 24, 2010
Summary
Different metal oxide nanoparticles cause unique lung inflammation in rats, indicating distinct hazards. Risk assessments must consider each nanoparticle type individually due to varying pathologies and severity.
Area of Science:
- Nanotoxicology
- Occupational Health
- Materials Science
Background:
- Metal oxide nanoparticles (NPs) are prevalent in industry, cosmetics, and biomedicine.
- Growing concerns exist regarding occupational inhalation exposure to high-production volume NPs.
Purpose of the Study:
- To assess the lung inflammation hazards of various well-characterized NPs.
- To differentiate the inflammatory responses induced by different NPs following inhalation exposure.
Main Methods:
- Instillation of NPs (cerium oxide, titanium dioxide, carbon black, silicon dioxide, nickel oxide, zinc oxide, copper oxide, polystyrene beads) into rat lungs.
- Evaluation of acute (24 hr) and chronic (4 weeks) inflammatory potencies and characteristics.
- Equal-surface-area doses were used for all exposures.
Main Results:
- Cerium oxide (CeO₂NP), nickel oxide (NiONP), zinc oxide (ZnONP), and copper oxide (CuONP) induced lung inflammation in rats.
- Each of these NPs elicited a unique acute and chronic inflammatory profile.
- Distinct patterns of neutrophil, eosinophil, and lymphocyte infiltrates, along with fibrotic and granulomatous responses, were observed for each inflammogenic NP.
Conclusions:
- Different NPs present unique hazards with varying pathologies and risk severities.
- In vitro testing is insufficient for differentiating these complex hazard outcomes.
- NP hazard assessment requires individual evaluation, as NPs are not a single hazard entity.
